EG19304A - Method of treating pre-menstrual syndrome - Google Patents

Method of treating pre-menstrual syndrome

Info

Publication number
EG19304A
EG19304A EG1690A EG1690A EG19304A EG 19304 A EG19304 A EG 19304A EG 1690 A EG1690 A EG 1690A EG 1690 A EG1690 A EG 1690A EG 19304 A EG19304 A EG 19304A
Authority
EG
Egypt
Prior art keywords
menstrual syndrome
treating pre
pms
menstrual
syndrome
Prior art date
Application number
EG1690A
Other languages
English (en)
Inventor
Michael Cohen
Original Assignee
Michael Cohen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27154756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG19304(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Michael Cohen filed Critical Michael Cohen
Application granted granted Critical
Publication of EG19304A publication Critical patent/EG19304A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
EG1690A 1989-01-17 1990-01-14 Method of treating pre-menstrual syndrome EG19304A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/297,328 US4945103A (en) 1989-01-17 1989-01-17 Method of treating pre-menstrual syndrome
AU51928/90A AU642864B2 (en) 1989-01-17 1990-02-09 Method of treating pre-menstrual syndrome
PCT/US1990/000154 WO1991012007A1 (fr) 1989-01-17 1990-02-09 Procede de traitement du syndrome pre-menstruel
CA002075904A CA2075904C (fr) 1989-01-17 1990-02-09 Methode de traitement du syndrome pre-menstruel

Publications (1)

Publication Number Publication Date
EG19304A true EG19304A (en) 1994-11-30

Family

ID=27154756

Family Applications (1)

Application Number Title Priority Date Filing Date
EG1690A EG19304A (en) 1989-01-17 1990-01-14 Method of treating pre-menstrual syndrome

Country Status (11)

Country Link
US (1) US4945103A (fr)
EP (1) EP0514373B1 (fr)
KR (1) KR0171408B1 (fr)
AT (1) ATE124260T1 (fr)
AU (1) AU642864B2 (fr)
CA (1) CA2075904C (fr)
DE (1) DE69020582T2 (fr)
EG (1) EG19304A (fr)
ES (1) ES2074565T3 (fr)
IL (1) IL93053A (fr)
WO (1) WO1991012007A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5116828A (en) * 1989-10-26 1992-05-26 Nippon Zoki Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of osteoporosis
US6638963B1 (en) 1990-12-04 2003-10-28 Oregon Health And Science University Methods for treating circadian rhythm disorders
US5707652A (en) * 1990-12-04 1998-01-13 State Of Oregon Methods of treating circadian rhythm phase disorders
DE122007000073I1 (de) * 1991-05-09 2008-01-31 Neurim Pharma 1991 Melatonin enthaltene Arzneimittel
AU660336B2 (en) * 1991-10-18 1995-06-22 Alza Corporation Device for the transdermal administration of melatonin
DE69303919T2 (de) * 1992-04-07 1997-01-30 Neurim Pharma 1991 Verwendung von Melatonin zur Herstellung eines Arzneimittels zur Behandlung der gutartigen Prostatahyperplasie
US5385736A (en) * 1993-07-12 1995-01-31 Minnesota Mining And Manufacturing Company Transdermal melatonin delivery system
WO1995003043A1 (fr) * 1993-07-26 1995-02-02 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Compositions administrees par voie orale, de type retard, contenant de la melatonine
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
CA2255838A1 (fr) * 1996-05-20 1997-11-27 Richard C. Fuisz Melatonine combinee a des analgesiques
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
US6479545B1 (en) 1999-09-30 2002-11-12 Drugtech Corporation Formulation for menopausal women
DE19957710A1 (de) * 1999-11-30 2001-05-31 Asat Ag Applied Science & Tech Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US20020119191A1 (en) * 2000-04-24 2002-08-29 Hitoo Nishino Pharmaceutical or food composition for treatment or prevention of brain edema
PL370889A1 (en) 2001-12-20 2005-05-30 Femmepharma, Inc. Vaginal delivery of drugs
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
WO2004060322A2 (fr) 2003-01-02 2004-07-22 Femmepharma Holding Company, Inc. Preparations pharmaceutiques permettant le traitement de maladies et d'affections du sein
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
SI1667678T1 (sl) 2003-10-03 2009-12-31 Veijlen N V Sestavek za ĺ˝ivalsko hrano
DK1670444T3 (da) 2003-10-03 2011-08-22 Veijlen N V Anvendelse af IFG-1-serumniveau forhøjende indoleddikesyrederivater til fremstilling af en lægemiddelsammensætning til behandling af forskellige sygdomme
KR100776294B1 (ko) * 2006-08-30 2007-11-16 엘지전자 주식회사 냉장고
KR100835183B1 (ko) * 2006-08-30 2008-06-04 엘지전자 주식회사 냉장고
US20090281518A1 (en) * 2006-09-13 2009-11-12 Koninklijke Philips Electronics N.V. Device for automatic adjustment of the dose of melatonin and/or delivery of melatonin
CN101677994B (zh) * 2007-04-11 2015-07-22 药品生产公司 褪黑激素片剂及制备和使用的方法
UY33103A (es) 2009-12-15 2011-07-29 Techsphere S A De C V Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
KR102262306B1 (ko) 2013-07-04 2021-06-09 (주)아모레퍼시픽 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물
KR102192573B1 (ko) 2020-08-12 2020-12-18 문종진 생리통 및 피부 트러블의 예방 및 개선용 조성물
CN113876689A (zh) * 2021-11-01 2022-01-04 冷静 一种改进型褪黑素的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
EP0126630B1 (fr) * 1983-05-18 1987-09-16 Monash University Utilisation de melatonine pour la fabrication d'un medicament
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
US4654361A (en) * 1986-01-27 1987-03-31 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University Method of lowering intraocular pressure using melatonin
NZ215767A (en) * 1986-04-09 1989-10-27 Nz Government Stimulating cashmere fibre growth on cashmere-producing goats by administration of melatonin
US4855305A (en) * 1987-03-23 1989-08-08 Applied Medical Research Compositions and methods of effecting contraception utilizing melatonin
EP0311651A1 (fr) * 1987-04-01 1989-04-19 Cellena (Cell Engeneering) A.G. Derives de melatonine pour stress psychogene et anxiete aigue, et medicaments immuno-stimulants

Also Published As

Publication number Publication date
US4945103A (en) 1990-07-31
CA2075904C (fr) 2004-07-20
WO1991012007A1 (fr) 1991-08-22
ES2074565T3 (es) 1995-09-16
ATE124260T1 (de) 1995-07-15
AU642864B2 (en) 1993-11-04
DE69020582T2 (de) 1996-01-04
EP0514373A4 (en) 1993-03-17
CA2075904A1 (fr) 1991-08-10
IL93053A (en) 1994-02-27
AU5192890A (en) 1991-09-03
KR920700649A (ko) 1992-08-10
DE69020582D1 (de) 1995-08-03
EP0514373A1 (fr) 1992-11-25
KR0171408B1 (ko) 1999-02-01
EP0514373B1 (fr) 1995-06-28

Similar Documents

Publication Publication Date Title
EG19304A (en) Method of treating pre-menstrual syndrome
HU9202072D0 (en) An improved method for treatment of autoimmunic diseases by means of introduction of autoantigenes in form of aerosol
EP0219524A1 (fr) Traitement du syndrome de detresse respiratoire chez l'adulte.
IE882391L (en) Pad printing process
GR3015510T3 (en) Treatment of neoplastic disease with interleukin-10.
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
PT92866A (pt) Metodo para o tratamento de sindroma pre-menstrual, utilizando melatonina
PL285854A1 (en) Therapeutical device, especially for treatment of sexual disorders in men
EP0904094A4 (fr) Traitement de maladies osseuses au moyen d'adrenomedulline
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
DE3377650D1 (en) Hydantoin therapeutic agents
HUT37030A (en) Therapeutic auxiliary device for the treatment of traumatological patients, first of all with lower limb fraction
MX9700626A (es) USO DE AZASPIRANOS EN LA REPARACIaN DE COMPOSICIONES PARA TRATAR INFECCIONES OPORTUNISTAS.
ZA897549B (en) Medicament for the treatment of diseases caused by retroviruses
EP0428272A3 (en) Trifluorobenzodiazepine compounds for use in therapy by intraoral administration
ES2011526A6 (es) Instalacion para la regeneracion y depouracion de la sangre.
EP0267402A3 (en) Use of follicle regulatory protein for the production of a therapeutic agent for the treatment of neoplasm of gonadal origin
IE880151L (en) Method for treatment of hyperacidity.
PL283664A1 (en) Therapeutical set for treating limb bone fractures by traction
IT1243947B (it) 2-azido-ornitina, sua preparazione e suo impiego in terapia
HUT59823A (en) Sensitivizing composition for ionizing rays and process for producing it
AU99667S (en) Physical therapy treatment table
SU1752411A1 (ru) Cпocoб лeчehия бoльhыx c hapушehhoй фуhkциeй koпуляции
GB8818556D0 (en) Novel therapeutic immunoconjugates for use in treatment of cancer